OBJECTIVE: When animals are allowed free access to food following an extended period of food restriction, body weight is steadily restored to the pre-food restriction level, ie to a specific body weight 'set-point'. We tested the proposition that leptin is used as a signal by the brain to regulate body weight 'set-point'. To this end, we determined whether long-term leptin infusion in rats would prevent the normal weight regain after food restriction. METHODS: Male Sprague -Dawley rats received leptin (leptin-treated) or saline (vehicle-treated) by intravenous infusion. After a 2 week run-in period, food intake was adjusted to 50% of each individual's normal intake for 12 days. Two days prior to the return of unlimited access to food, one group of animals received continuous leptin infusion at 3 mg=h for the next 14 days. Blood samples taken from the tail vein were used to determine leptin concentrations. A third group of animals that did not undergo food restriction but received saline infusion served as control. As leptin acts in the brain to modulate neuropeptide Y (NPY) levels, hypothalamic NPY content was measured at the end of the study. RESULTS: Food restriction to 50% normal intake for 12 days induced a 20% weight loss and significant reductions in plasma leptin compared with non-restricted control rats (0.5 AE 0.1 vs 2.6 AE 0.4 ng=ml, P < 0.05). Intravenous infusion of leptin increased leptin concentrations four-fold compared with vehicle-treated animals (9.5 AE 1.3 vs 2.2 AE 0.4 ng=ml, P < 0.05). The infusion of leptin attenuated the increase in daily food intake after free access to food was resumed (P < 0.05 at 4, 6 and 8 days). Despite this, both groups of previously restricted rats had regained the same amount of weight after 12 days of ad libitum feeding. No difference was noted in NPY levels measured in the arcuate nucleus and the paraventricular nucleus, in line with the similar amounts of food eaten by all rats at the end of the experiment. CONCLUSION: Increasing plasma leptin concentrations just prior to the end of a period of food restriction reduced subsequent food intake, but did not appear to exert a major influence on the body weight 'set-point', as leptin did not prevent weight regain. The results of the present study suggest that leptin may be of little value in maintaining weight loss in individuals who have lost weight through dieting. Further research is required to understand the role of leptin in the regulation of energy balance.
Introduction
In the long term, an individual's body weight is controlled by interplay between various environmental and physiological factors controlling energy input and expenditure. Central nervous system mechanisms have evolved that coordinate the animal's behavioural and physiological responses in order to achieve and maintain the appropriate body weight. The brain senses and interprets neural, endocrine and metabolic signals and activates distinct effector pathways to regulate energy intake and expenditure. 1 The importance of the hypothalamus in the control of food intake has been known for several decades. Selective ablation of the ventromedial hypothalamus produces hyperphagia and obesity, while destruction of the lateral hypothalamus (LH) results in weight loss. 2, 3 Experiments have also shown that after a period of food restriction, LH-lesioned rats restore their weight to a reduced level, 4 suggesting that the LH region is involved in the regulation of the body weight 'set point'. The 'set point' has been proposed as a body weight that is physiologically regulated, where intake and expenditure of energy are adjusted in order to maintain this level. 5, 6 Supporting this are observations that deprived animals and humans usually re-gain their weight after dietary restraints are removed. 6, 7 There are a number of central effector pathways in the hypothalamus involved in regulating appetite which are thought to be influenced by body adiposity, resulting in long-term stability of fat stores. 1 The concept that humoral signals generated in proportion to body fat stores, act in the brain to regulate body weight and adiposity 8 was strengthened by the discovery of mutations in obese mice 9, 10 and, subsequently, the discovery of leptin. Leptin, a 167-amino-acid protein encoded by the ob gene, 11 is produced by white adipose cells, such that obese humans and other mammals have increased adipose ob RNA and serum leptin levels. 12 -14 Leptin circulates partially bound to proteins 15 and enters the brain via a saturable transport mechanism. 16 The actions of leptin are mediated by the activation of Ob-Rb receptors found predominantly in the hypothalamus, 17, 18 where it stimulates anorexigenic peptides such as a-melanocyte-stimulating hormone (a-MSH) and cocaine-and amphetamine-regulated transcript (CART) and inhibits the expression of orexigenic peptides such as neuropeptide Y (NPY), melanin-concentrating hormone (MCH) and agouti-related peptide (AgRP; reviewed in Schwartz et al 1 ). While circulating leptin concentrations are closely related to adipose tissue mass, plasma leptin concentrations also respond to acute changes in food intake. Leptin levels increase in rodents within hours after a meal 19 and in humans after several days of overfeeding, 20 but decrease in both species within hours after initiation of fasting. Circulating leptin also exhibits a diurnal pattern with highest levels at night. 21 Leptin has been considered an anti-obesity hormone 22 as its administration to rodents decreases food intake and increases energy expenditure, with weight loss primarily due to loss of adipose tissue, although some loss of lean mass may occur. 23 -26 There is a strong correlation between the circulating concentration of leptin and body weight, so leptin can act as a signal to the brain regarding adiposity levels. 12, 14, 27 During a period of food restriction, when leptin concentration is decreased due to fat loss, central mechanisms responding to decreased leptin would act to coordinate orexigenic systems, 12, 14 which may explain why most individuals and rodents re-gain their weight after dietary restraints are removed, 6 ,7 a concept which has also been suggested by Flier. 28 This study examined the effect of leptin administration on the regain of body weight and food intake after a period of food restriction in the rat. Fat mass and brain NPY levels were also determined, since food restriction decreases leptin levels, leading to an increase in NPY expression. We hypothesized that if plasma leptin concentrations were returned to pre-restricted levels, the drive to eat would be diminished and the weight regain after food restriction would be delayed. Recent work on juvenile rats supports a role of leptin in regulating fat mass and body weight at leptin concentrations within the physiological range. 27 In the present study we aimed for leptin levels within the range of plasma concentrations achieved under physiological conditions such as voluntary overeating rather than supraphysiological concentrations, as these are more likely to be clinically relevant.
Materials and Methods

Animals
Experiments were performed on male Sprague -Dawley rats housed two per cage. The cage was divided in half by a wire screen to allow individual food and water intake to be monitored while allowing contact between rats. All rats were acclimated for at least 12 days prior to the day of surgery. Body weight, food and water intakes were measured daily for the duration of the study. The Animal Ethics Committee of the Howard Florey Institute approved all procedures.
Experimental protocol
Rats were anaesthetized with equithesin (3 ml=kg, i.p.) and the femoral vein was cannulated using polyethylene tubing containing heparinized saline (50 units=ml). The cannula was secured and externalized at the neck, then connected to an osmotic pump implanted subcutaneously (model 2ML2, Alza Corp., Palo Alto, CA, USA). All rats received i.v. saline at 5 ml=h for the first 2 weeks of the study.
Four days post surgery (day 0) rats, average weight 283.2 AE 2.9 g (n ¼ 21), were divided into three groups. The first group (control group, n ¼ 6) had ad libitum food intake (standard rat chow, Barastoc G.R.2, Rat and Mouse Breeder Ration, Ridley Agriproducts Pty. Ltd, St Arnauds, Australia) for the entire experiment. The other two groups received 50% of their normal daily chow intake for 12 days. On day 10, all animals were anaesthetized for a short period (Brietal Sodium, 40 mg=kg, i.p.) to allow changeover of osmotic pumps. The control and vehicle-treated (n ¼ 8) groups continued to receive i.v. saline, while the third group received murine leptin dissolved in saline at 0.6 mg=ml, resulting in a delivery of 3 mg=h (leptin-treated group, n ¼ 7). The dose was selected on the basis of dose -response data for leptin effects on body mass and food intake on rats 29 and mice. 26 Following the restriction period, food was returned on day 12 and rats were monitored for a further 12 days while receiving ad libitum food.
Blood samples (0.3 ml) were obtained on days 0, 5, 12, 14 and 17 from the tail vein of previously warmed and gently restrained rats. Animals become accustomed to the procedure and do not show any outward sign of stress. On day 24, cardiac blood (3 ml) was obtained from deeply anaesthetised (pentobarbitone sodium; 100 mg=kg, i.p.) rats. The blood was centrifuged (12 000 rpm, 25 C, 8 min) and the separated plasma was stored at 720 C for subsequent determination of plasma leptin.
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Tissue collection
On day 24, following collection of cardiac blood, the animals were decapitated to allow for the rapid removal of the brain. Serial coronal sections were made on ice starting at the rostral border of the hypothalamus, which were then dissected into areas containing the paraventricular nucleus (PVN), anterior and posterior hypothalamus, arcuate nucleus (ARC) and preoptic area (PO), as previously described. 30 The brain regions were weighed and stored at 780 C for subsequent determination of NPY. Heart, liver and kidney were dissected for comparison of organ weights. Left retroperitoneal white adipose tissue (RpWAT), gonadal WAT and interscapular brown adipose tissue (iBAT) were measured to examine the effects on adipose tissue. The length of the right tibia was also measured.
Leptin and NPY measurement
Plasma leptin concentrations were measured with a commercially available radioimmunoassay kit (Linco, St Charles, MO, USA), using rat leptin as standards (0.5 -50 ng=ml). This assay shows 100% cross-reactivity with both mouse and rat leptin. Inter-and intra-assay co-efficients of variation were 4 and 2%, respectively.
NPY was extracted from PVN, ARC, anterior and posterior hypothalamus and PO by boiling the brain tissue in 0.5 M acetic acid for 10 min, followed by homogenisation and centrifugation at 7500 rpm for 35 min at 4 C (Beckman J2MI). The supernatant was decanted, weighed and 50 ml was lyophilized, then reconstituted with assay buffer (0.04 M sodium phosphate buffer containing 0.01 M NaCl, 0.02% NaN 3 , 0.25% BSA, pH 7.3). NPY-like immunoreactivity (NPY-LI) was measured using synthetic NPY as a standard (10 -1280 pg=tube, Auspep, Australia) and Bolton Hunter labelled 125 I-NPY (2000 Ci=mmol, Amersham Pharmacia Biotech UK, Buckinghamshire HP, England). 30 This method has been previously used to discern differences in peptide content resulting from diet-induced 30 and genetic 31 obesity, and weight loss following vagotomy. 32 
Drugs
Murine leptin was purchased from ICN Biomedicals, Aurora, USA. Leptin was reconstituted in saline and acetic acid at pH 4. The pH was then adjusted using ammonium hydroxide. Brietal Sodium and pentobarbitone sodium were purchased from Eli Lilly and Company (Sydney, Australia) and Boehringer Ingelheim Pty Ltd (Artarmon, Australia) respectively.
Statistics
Results are expressed as mean AE s.e.m. Data for food and water intake are presented as an average over a two-day period. Body weight, food and water intake and plasma leptin levels were analysed by ANOVA with repeated measures, followed by a post hoc least significant difference (LSD) test (Statistica, Statsoft). Organ weights, fat mass and NPY levels were analysed using one-way ANOVA.
Results
Body weight changes
The body weights of all animals dropped slightly following surgery, however most recovered within 4 days. Both groups of animals that underwent food restriction showed a significant decrease in body weight relative to the non-restricted control group after only two days of 50% food deprivation (Figure 1) . By day 12 of food restriction, the leptin-and vehicle-treated groups had lost 11% of their body weight relative to their own starting weight and were 20% lighter than the control group (Figure 1) .
After food-restriction, there was a large increase in body weight over the first 2 days following ad libitum access to food in both the vehicle-and leptin-treated animals. Thereafter, a slower rate of weight gain was maintained. The pattern of weight gain during the 12 day period of ad libitum food access was similar for vehicle-and leptin-treated animals. However, animals receiving leptin remained significantly lighter than the non-restricted control group for 6 days, 2 days longer than did the vehicle-treated animals ( Figure 1 ).
Food and water intake
All rats decreased their food intake after surgery and the changing of the pump (Figure 2) . Following the 12 day food restriction period, both vehicle-and leptin-treated animals immediately increased their food intake. Both groups ate Figure 1 Body weight of non-restricted control (.) and restricted vehicle-(u) and leptin-treated (n) groups of Sprague -Dawley rats during ad libitum food intake (open bar) and food restriction (shaded bar). Results are expressed as mean AE s.e.m. (control, n ¼ 6; vehicle, n ¼ 8; leptin, n ¼ 7), where each point represents an average over 2 days. Data were analysed by one-way ANOVA with repeated measures followed by post hoc least significant difference tests. *P < 0.05, significant difference between non-restricted control group and both food restricted groups. # P < 0.05, significant difference between nonrestricted control group and leptin-treated group only.
Leptin and body weight regain E Velkoska et al 25% more than the control group over the first 2 days of ad libitum access to food (P < 0.05). However, after the first 2 days, the leptin-treated group returned to control levels of chow intake, significantly lower than the vehicle-treated group, which continued to eat more for another 6 days relative to the non-restricted control and leptin-treated groups ( Figure 2 ). The pattern of water intake was similar to that of food intake, with the vehicle-and leptin-treated groups drinking significantly less during the food restriction period, compared with the non-restricted control group (results not shown).
Changes in plasma leptin concentration
As shown in Figure 3 , before the commencement of food restriction, all three treatment groups had relatively similar basal leptin levels (day 0), and a significant correlation between leptin and body weight was observed (r ¼ 0.55, P < 0.05). The plasma leptin of the non-restricted control group appeared to increase over time, in line with their increasing body weight, however there was no significant difference between leptin concentration at the beginning and end of the experimental period. After 5 days of food restriction, plasma leptin of both restricted groups decreased by approximately 68% relative to their own basal levels (vehicle 0.5 AE 0.1 vs 1.6 AE 0.2 ng=ml, n ¼ 8; leptin: 0.9 AE 0.3 vs 2.7 AE 0.6 ng=ml, n ¼ 7, both P < 0.05). When compared to the non-restricted control group at the same time point (2.6 AE 0.4 ng=ml, n ¼ 6; Figure 3 ), leptin concentrations of the food restricted groups were reduced by 75%.
Leptin infusion at 3 mg=h increased the plasma leptin concentration to three times the basal level. Compared to the non-restricted control group, leptin concentration had increased four-fold (9.3 AE 1.3 vs 2.3 AE 0.4 ng=ml; P < 0.05) in the first 2 days of leptin infusion. Leptin decreased slightly over the following 12 days, however it remained significantly higher than both the control and vehicle-treated groups ( Figure 3 ) and did not seem to be greatly affected by the return of ad libitum access to food.
Two days after food was returned, the plasma leptin concentration of the vehicle-treated group had increased Figure 2 Food intake of non-restricted control (.) and restricted vehicle-(u) and leptin-treated (n) groups of Sprague -Dawley rats during ad libitum food intake (open bar) and food restriction (shaded bar). Results were expressed as mean AE s.e.m., where each point represents the average food intake over 2 days (control, n ¼ 6; vehicle, n ¼ 8; leptin, n ¼ 7). Data was analysed by one-way ANOVA with repeated measures followed by post hoc least significant difference tests. *P < 0.05 significantly different from non-restricted control group. Leptin and body weight regain E Velkoska et al four-fold, returning to their basal level, and was equivalent to that of the non-restricted control rats. However, 5 and 12 days after food was returned, the leptin concentration was significantly greater than their basal levels ( Figure 3 ).
Hypothalamic NPY content
At the end of the study, NPY content was measured in five different areas of the hypothalamus, of which the ARC and PVN are known to be particularly important in feeding regulation. No significant differences were observed between the three treatment groups in any of the areas of the hypothalamus (Figure 4) .
Organ weights and adiposity
The leptin-treated group showed a significantly lower mass of gonadal WAT when compared to the non-restricted control rats, but not compared to the vehicle-treated rats. No difference in RpWAT mass was observed (Table 1) . Only two fat depots were measured in this study and it is noteworthy that whole body fat analysis would be necessary to detect small regional changes in fat deposition. The iBAT of both food restricted groups was significantly lower than that of the control group. There was no significant difference in tibia length or organ mass between the three groups of animals ( Table 1) .
Discussion
It has been proposed that each individual has a body weight 'set-point' that is physiologically regulated, where intake and expenditure of energy are adjusted in order to maintain this level. 4, 33 Consistent with this proposition, the results of the present study show that food deprived rats regained their weight after the dietary restraint was removed. Restriction to 50% of normal daily food intake over 12 days, decreased body weight by 20% and plasma leptin levels by 75%, consistent with previous work. 12, 14, 29, 34 In order to examine whether the decreased plasma leptin seen in times of weight loss is a signal to regain weight as soon as the opportunity arises, we artificially raised plasma leptin levels. The leptin infusion, beginning 2 days prior to the end of food restriction, and continuing throughout a subsequent period of unrestricted food access, rapidly elevated plasma leptin concentrations above control levels. Despite the increase in leptin, recovery of body weight was delayed little, if at all, and at the completion of the study there was no difference in fat mass between vehicle-and leptin-treated rats. This indicates that contemporary plasma leptin concentrations are not the key signal determining the regain of body weight. The complex systems that are involved in body weight regulation can clearly counter-regulate a rapid increase in leptin, hence diminishing any effect that leptin may have on the system. Increased hunger following food restriction was clearly evident as rats from both the vehicle-and the leptin-treated groups ate significantly more than the control rats once food was returned. However, vehicle-treated animals overate for 8 days whereas leptin-treated animals overate for only two days. This difference is consistent with previously reported effects of leptin on food intake immediately following fasting or food restriction. 29, 34 While this difference in food intake had a transient effect on body weight regain, the effect was not sustained. This dichotomy of effects is perhaps the most interesting finding of this study. Most other studies have concentrated on the food intake and body weight changes in the hours and days following re-feeding. 29 However, we have shown that, beyond this immediate stage, leptin had no effect on food intake or body weight regain, a result which suggests that modest changes in leptin may be insufficient to markedly affect body weight in the long term. The present data, however, do not exclude the possibility that small but physiologically relevant changes in total body fat content, too small to noticeably affect body weight, might occur in response to these modest changes in leptin.
Although it is well documented that leptin administration can reduce body weight, decrease food consumption and increase energy expenditure, most studies have been carried out in rodents with leptin deficiency or insensitivity, 23, 25 or have involved treatment with supraphysiological doses of leptin. 24 Other studies in mice and humans have shown that leptin administration can blunt the decrease in energy expenditure that occurs during food deprivation. 26, 35 If a rise in circulating levels of leptin had increased thermogenesis, it would have presumably been more difficult for the rats to regain their lost weight in our study. It is probable that, at the dose of leptin used, its effect on energy expenditure under our conditions of rapid weight regain was modest. Previous work has shown that higher doses of leptin are needed to increase uncoupling protein 1 expression in BAT relative to those required to reduce food intake. 36 Thus our work has shown for the first time that, while that leptin may support weight loss, 35 it may not prevent regain. Leptin and body weight regain E Velkoska et al Many studies investigating the physiological effects of leptin have administered the protein in one or two daily injections, which can cause irregular elevations of leptin concentration. 23 -25 Our results show a noticeable decrease in plasma leptin concentration during treatment, despite continuous infusion of leptin. The decrease in plasma leptin could be due to a decrease in production of leptin by adipose tissue as a result of administration of exogenous leptin. Wang and associates 37 reported that increasing plasma leptin concentration in rats led to a considerable decrease in leptin mRNA in adipose tissue via an autoregulatory feedback system.
It is thought that leptin decreases food intake and body weight, in part, by reducing hypothalamic NPY. 18, 22, 31 Food deprivation is associated with increased hypothalamic NPY content 38, 39 and when food is returned after a period of food deprivation, NPY levels return to control within 24 -48 h. 38, 39 It is likely that in vehicle-treated rats increased NPY concentrations post-food deprivation decline over several days, under the influence of rising endogenous leptin levels. However in leptin-treated rats, this decline in NPY may have been hastened by the additional exogenous leptin, which may explain the reduced food intake in leptin-treated vs vehicletreated rats immediately after food was returned. In the current experiment, hypothalamic NPY content was not affected at the end of the study, in line with the similar food consumption and body weight in leptin-and vehicle-treated rats and non-restricted controls at that time. Previous work in our laboratory has indicated that large changes in food intake are required to alter brain levels of NPY. 30, 32 Using vagotomized rats we have previously demonstrated a significant negative correlation between plasma leptin and ARC NPY levels. 32 However leptin concentrations varied more widely than in the present study, suggesting leptin may need to be elevated to a greater extent than we achieved to have a marked effect on NPY expression. 32 This is in line with recent work done using central leptin gene therapy showing that only a high dose of leptin can decrease the expression of NPY. 40 In conclusion, the current study has shown that low-dose leptin administration may reduce food intake acutely after a period of severe food restriction, but cannot alter the weight regain in the long-term after rapid weight loss.
Perspectives
Although short-term weight loss is often possible, sustained weight loss is not often attained. Despite initial hopes, results from recent clinical trials suggest that leptin will not be the 'magic bullet' for treating obesity. Overall, the effects of leptin are modest at best, possibly due in part to leptin resistance. 41 Several studies have evaluated the safety and efficacy of recombinant leptin administration. One involved a number of leptin-deficient subjects 42 and the second was a double blind, placebo-controlled, escalating dose cohort trial in both lean and obese subjects. 43 While leptin resulted in a decline in appetite, food intake and body weight in one study, 42 others reported considerable variability in weight loss, suggesting that leptin may only be effective in a subset of leptin-resistant obese subjects. 43 On the other hand, a third study reported a significant suppression of appetite with no significant changes in body weight using recombinant human leptin. 35 The results of the present study suggest that leptin may be of little value in maintaining weight loss in individuals who have lost weight through dieting. Further research is required to understand the role of leptin in the regulation of energy balance and to determine the future of leptin in the treatment of obesity.
